• For treatment of patients with neovascular (wet) age-related macular degeneration (AMD)• For treatment of adult patients with visual impairment due to diabetic macular oedema (DME)• For treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (RVO)• For treatment of visual impairment due to choroidal neovascularization (CNV)• For treatment of proliferative diabetic retinopathy (PDR)